ARO BIOTHERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 12 Sept 2022)
What this means for you
This application is over — abandoned 12 Sept 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88071501
- Mark type
- Stylized text
- Filed
- 09 Aug 2018
- Published for opposition
- 11 Jun 2019
- Abandoned
- 12 Sept 2022
- Attorney of record
- Sean P. McConnell
Goods and services
- Class 040 — Treatment of materials: Manufacturing for others of pharmaceuticals and biopharmaceuticals for the treatment of diseases with high morbidity and mortality rates
Owner
- Aro Biotherapeutics Company, Philadelphia, PA, US
- Aro Biotherapeutics Company, Philadelphia, PA, US
Prosecution history
- 12 Sept 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 12 Sept 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 09 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Feb 2022 — SOU EXTENSION 5 GRANTED
- 04 Feb 2022 — SOU EXTENSION 5 FILED
- 04 Feb 2022 — SOU TEAS EXTENSION RECEIVED
- 31 Aug 2021 — CORRECTED NOA E-MAILED
- 24 Aug 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Aug 2021 — DIVISIONAL PROCESSING COMPLETE
- 06 Aug 2021 — DIVISIONAL REQUEST RECEIVED
- 23 Aug 2021 — SOU EXTENSION 4 GRANTED
- 06 Aug 2021 — SOU EXTENSION 4 FILED
- 06 Aug 2021 — TEAS REQUEST TO DIVIDE RECEIVED
- 06 Aug 2021 — SOU TEAS EXTENSION RECEIVED
- 10 Feb 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED